P2P, or not P2P, that is the question
As the 16 January, 2015 deadline for responding to the controversial P2P draft report draws near, and in the interests of balance and representing the whole community, Phoenix Rising presents two differing views on how to react. Today, Clark Ellis flags up important content to...
Discuss the article on the Forums.

University of Florida Phase 3 Trial on CoQ10, for kids 12 to 17

Discussion in 'Active Clinical Studies' started by ggingues, Oct 20, 2010.

  1. ggingues

    ggingues $10 gift code at iHerb GAS343 of $40

    Messages:
    4,214
    Likes:
    1,044
    Concord, NH
    The University of Florida is continuing to recruit patients for a clinical trial to investigate the safety and effectiveness of Coenzyme Q10 (CoQ10) as a treatment for children with specific mitochondrial diseases.

    CoQ10 is a mitochondrial cofactor and antioxidant in the process that cells use to convert food and oxygen into energy.

    To be considered for the trial, patients must be 12 months to 17 years of age and have a biochemical or molecular diagnosis of a deficiency of complex I, III or IV of the respiratory chain.

    For additional information contact Courtney Yates, RN, at Courtney.Yates@medicine.ufl.edu or at 352-273-9016.
     

See more popular forum discussions.

Share This Page